HEK293 Cell Line as a Platform to Produce Recombinant Proteins and Viral Vectors
Animal cell-based expression platforms enable the production of complex biomolecules such as recombinant proteins and viral vectors. Although most biotherapeutics are produced in animal cell lines, production in human cell lines is expanding. One important advantage of using human cell lines is the increased potential that the resulting biotherapeutics would carry more “human-like” post-translational modifications. Among the human cell lines, HEK293 is widely utilized due to its high transfectivity, rapid growth rate, and ability to grow in a serum-free, suspension culture. In this review, we discuss the use of HEK293 cells and its subtypes in the production of biotherapeutics. We also compare their usage against other commonly used host cell lines in each category of biotherapeutics and summarise the factors influencing the choice of host cell lines used.
Top-30
Journals
|
1
2
3
4
5
|
|
|
International Journal of Molecular Sciences
5 publications, 2.91%
|
|
|
Frontiers in Bioengineering and Biotechnology
5 publications, 2.91%
|
|
|
Molecular Therapy - Methods and Clinical Development
5 publications, 2.91%
|
|
|
Biotechnology Advances
4 publications, 2.33%
|
|
|
Vaccines
4 publications, 2.33%
|
|
|
BMC Biotechnology
3 publications, 1.74%
|
|
|
PLoS ONE
3 publications, 1.74%
|
|
|
Frontiers in Immunology
3 publications, 1.74%
|
|
|
ACS Omega
3 publications, 1.74%
|
|
|
Methods in Molecular Biology
3 publications, 1.74%
|
|
|
Bioengineering
2 publications, 1.16%
|
|
|
Biotechnology and Bioengineering
2 publications, 1.16%
|
|
|
Fine Chemical Technologies
2 publications, 1.16%
|
|
|
bioRxiv
2 publications, 1.16%
|
|
|
Nucleic Acids Research
2 publications, 1.16%
|
|
|
Antibodies
2 publications, 1.16%
|
|
|
Journal of Chromatography A
2 publications, 1.16%
|
|
|
Current Issues in Molecular Biology
2 publications, 1.16%
|
|
|
iScience
2 publications, 1.16%
|
|
|
Nature Communications
2 publications, 1.16%
|
|
|
Cells
2 publications, 1.16%
|
|
|
ACS Biomaterials Science and Engineering
2 publications, 1.16%
|
|
|
Advanced Science
2 publications, 1.16%
|
|
|
Pharmaceutics
2 publications, 1.16%
|
|
|
Journal of Biotechnology
2 publications, 1.16%
|
|
|
Cell Biochemistry and Function
1 publication, 0.58%
|
|
|
Sensors
1 publication, 0.58%
|
|
|
Virus Research
1 publication, 0.58%
|
|
|
Cytotherapy
1 publication, 0.58%
|
|
|
1
2
3
4
5
|
Publishers
|
5
10
15
20
25
30
35
40
|
|
|
Elsevier
39 publications, 22.67%
|
|
|
MDPI
30 publications, 17.44%
|
|
|
Springer Nature
20 publications, 11.63%
|
|
|
Wiley
15 publications, 8.72%
|
|
|
Cold Spring Harbor Laboratory
14 publications, 8.14%
|
|
|
Frontiers Media S.A.
10 publications, 5.81%
|
|
|
American Chemical Society (ACS)
8 publications, 4.65%
|
|
|
Public Library of Science (PLoS)
4 publications, 2.33%
|
|
|
Oxford University Press
4 publications, 2.33%
|
|
|
Pleiades Publishing
3 publications, 1.74%
|
|
|
RTU MIREA
2 publications, 1.16%
|
|
|
Royal Society of Chemistry (RSC)
2 publications, 1.16%
|
|
|
Research Square Platform LLC
2 publications, 1.16%
|
|
|
Canadian Science Publishing
1 publication, 0.58%
|
|
|
SAGE
1 publication, 0.58%
|
|
|
PeerJ
1 publication, 0.58%
|
|
|
Acta Naturae Ltd
1 publication, 0.58%
|
|
|
Academic Journals
1 publication, 0.58%
|
|
|
Eco-Vector LLC
1 publication, 0.58%
|
|
|
IntechOpen
1 publication, 0.58%
|
|
|
American Association for the Advancement of Science (AAAS)
1 publication, 0.58%
|
|
|
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 0.58%
|
|
|
Mary Ann Liebert
1 publication, 0.58%
|
|
|
IOP Publishing
1 publication, 0.58%
|
|
|
The Company of Biologists
1 publication, 0.58%
|
|
|
Bentham Science Publishers Ltd.
1 publication, 0.58%
|
|
|
Federal Medical Biological Agency
1 publication, 0.58%
|
|
|
Hindawi Limited
1 publication, 0.58%
|
|
|
5
10
15
20
25
30
35
40
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.